Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Codexis, Inc. (CDXS) Institutional Ownership & Insider Trading

149 institutions reported holding Codexis, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 27 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CDXSCodexis, Inc.Follow CDXS — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
140.2M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
29 Oct, in 5 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

149 institutions held 63.7% of the shares. Across filers that reported both quarters, shares held changed +6.6%.

Increased+61New+25Decreased-33Closed-9

Largest moves, shares (millions)

Nantahala Capital Management+3.1MAssenagon Asset Management…+1.8MMillennium Management+1.6MUBS Group AG-1.9MAberdeen Group-1.9MPrivate Advisor Group-0.8M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+6.8Sep 24+0.4Dec 24+1.7Mar 25+6.0Jun 25-5.6Sep 25-1.6Dec 25+0.7Mar 26+4.3Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2614970+6.6%6125339
Mar 2613365+1.1%47272920
Dec 2512565-2.4%46113220
Sep 2513066-7.9%28194110
Jun 2512071+9.3%3594213
Mar 2512465+2.7%45103721
Dec 2413264+0.7%5219278
Sep 2411663+14.1%3863110

Codexis, Inc. — questions

Who owns Codexis, Inc. stock?
149 institutions reported Codexis, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (6.7%), Nantahala Capital Management, LLC (6.6%), Opaleye Management Inc. (6.2%).
Are Codexis, Inc. insiders buying or selling?
27 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Codexis, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.